Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCARM Institute (Stem Cell and Regenerative Medicine Institute) is a specialized clinical and research organization based in Bhubaneswar, India, focused on the application of regenerative medicine. The institute provides stem cell-based therapies for a variety of neurological, orthopedic, and lifestyle-related conditions that are often considered incurable by conventional medicine. Their primary therapeutic approach utilizes autologous bone marrow-derived mononuclear cells (BMMNCs) to treat indications such as autism spectrum disorder, cerebral palsy, and spinal cord injuries. In addition to clinical services, SCARM Institute engages in translational research and offers professional training programs in stem cell technology. The organization aims to bridge the gap between laboratory research and clinical practice to provide advanced treatment options for patients with limited medical alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCARM Institute.